title: Metformin nephrotoxicity insights: will they change clinical management?
authors.affiliation: Department of Medicine, Section of Endocrinology, Diabetes and Metabolism, the ASH Comprehensive Hypertension Center, The University of Chicago Medicine, Chicago, Illinois, USA.
authors.forename: Celeste C
authors.initials: CC
authors.lastname: Thomas
authors.forename: George
authors.initials: G
authors.lastname: Bakris
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced; D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004358:Drug Therapy / Q000379:methods / Q000639:trends; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D008687:Metformin / Q000009:adverse effects / Q000627:therapeutic use*; D051379:Mice
chemical_list: D007004:Hypoglycemic Agents; D008687:Metformin